Suppr超能文献

用于治疗骨质疏松症的有机硝酸盐:最新进展

Organic nitrates for osteoporosis: an update.

作者信息

Hamilton Celeste J, Reid Lauren S, Jamal Sophie A

机构信息

Multidisciplinary Osteoporosis Research Program, Women's College Hospital, University of Toronto , Toronto, Ontario, Canada ; Department of Exercise Sciences, University of Toronto, Women's College Research Institute , Toronto, Ontario, Canada.

Multidisciplinary Osteoporosis Research Program, Women's College Hospital, University of Toronto , Toronto, Ontario, Canada.

出版信息

Bonekey Rep. 2013 Feb 6;2:259. doi: 10.1038/bonekey.2012.259.

Abstract

The number of osteoporotic fractures is increasing worldwide as populations age. An inexpensive and widely available treatment is necessary to alleviate this increase in fractures. Current treatments decrease fractures at trabecular bone sites (spine) but have limited effects at cortical sites (hip, legs, forearm and upper arm)-the most common sites of osteoporotic fracture. Treatments are also limited by costs, side effects and lack of availability. Nitric oxide (NO) is a novel agent that has the potential to influence cortical bone, is inexpensive, widely available and has limited side effects. In this review, we will evaluate the in vitro and in vivo data that support the concept that NO is important in bone cell function, review the observational, case control and randomized trial data on organic nitrates and the effects of these agents on bone turnover, geometry and strength.

摘要

随着全球人口老龄化,骨质疏松性骨折的数量正在增加。需要一种廉价且广泛可用的治疗方法来缓解骨折数量的增加。目前的治疗方法可减少小梁骨部位(脊柱)的骨折,但对皮质骨部位(髋部、腿部、前臂和上臂)——骨质疏松性骨折最常见的部位——效果有限。治疗方法还受到成本、副作用和可用性的限制。一氧化氮(NO)是一种新型药物,有可能影响皮质骨,价格低廉、广泛可用且副作用有限。在本综述中,我们将评估支持NO在骨细胞功能中起重要作用这一概念的体外和体内数据,回顾关于有机硝酸盐的观察性、病例对照和随机试验数据,以及这些药物对骨转换、骨几何形状和强度的影响。

相似文献

1
Organic nitrates for osteoporosis: an update.
Bonekey Rep. 2013 Feb 6;2:259. doi: 10.1038/bonekey.2012.259.
2
Nitric oxide donors for the treatment of osteoporosis.
Curr Osteoporos Rep. 2012 Mar;10(1):86-92. doi: 10.1007/s11914-011-0087-7.
3
The effects of organic nitrates on osteoporosis: a systematic review.
Osteoporos Int. 2013 Mar;24(3):763-70. doi: 10.1007/s00198-012-2262-9. Epub 2013 Jan 11.
5
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
7
A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
Spine J. 2007 Jul-Aug;7(4):466-74. doi: 10.1016/j.spinee.2006.06.400. Epub 2007 Apr 6.
9
Water fluoridation and osteoporotic fracture.
Community Dent Health. 1996 Sep;13 Suppl 2:63-8.

引用本文的文献

1
Repurposing erectile dysfunction drugs tadalafil and vardenafil to increase bone mass.
Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14386-14394. doi: 10.1073/pnas.2000950117. Epub 2020 Jun 8.
2
Inhibition of MSTN signal pathway may participate in LIPUS preventing bone loss in ovariectomized rats.
J Bone Miner Metab. 2020 Jan;38(1):14-26. doi: 10.1007/s00774-019-01029-5. Epub 2019 Aug 14.
3
A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
J Bone Miner Res. 2017 Jan;32(1):46-59. doi: 10.1002/jbmr.2909. Epub 2016 Sep 7.

本文引用的文献

2
Use of organic nitrates and the risk of hip fracture: a population-based case-control study.
J Clin Endocrinol Metab. 2010 Apr;95(4):1924-31. doi: 10.1210/jc.2009-2342. Epub 2010 Feb 3.
3
Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss.
J Clin Endocrinol Metab. 2009 Sep;94(9):3356-64. doi: 10.1210/jc.2008-2225. Epub 2009 Jun 23.
4
Decreased fracture risk in users of organic nitrates: a nationwide case-control study.
J Bone Miner Res. 2006 Nov;21(11):1811-7. doi: 10.1359/jbmr.060804.
6
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.
J Biol Chem. 2005 May 20;280(20):19883-7. doi: 10.1074/jbc.M413274200. Epub 2005 Mar 18.
7
Isosorbide mononitrate increases bone formation and decreases bone resorption in postmenopausal women: a randomized trial.
J Bone Miner Res. 2004 Sep;19(9):1512-7. doi: 10.1359/JBMR.040716. Epub 2004 Jul 26.
8
Natural history of bone loss over 6 years among premenopausal and early postmenopausal women.
Am J Epidemiol. 2002 Sep 1;156(5):410-7. doi: 10.1093/aje/kwf049.
9
Epidemiology and outcomes of osteoporotic fractures.
Lancet. 2002 May 18;359(9319):1761-7. doi: 10.1016/S0140-6736(02)08657-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验